ICONOVO is a Swedish company developing inhalation devices for licensing to customers. Every device will be based on an ICONOVO proprietary platform but customized and adapted to the customer’s unique needs. Together with our partners, ICONOVO can offer a comprehensive package including device, formulation, analytical testing, documentation etc. together with a complete supply chain.
Johan has over 17 years’ of experience within commercial management, commercial development, new company establishment and business partnership roles in the pharmaceutical industry across multiple geographies including Nordics, Europe, Russia, Latin America, Middle East, Northern Africa. Johan holds a MSc in Chemical engineering, at the faculty of engineering at Lund University (LTH) and ETH Zurich. He also serves as Board member and owner of Phigalia AB. Previously, Johan served as General Manager at Actelion Pharmaceuticals Sverige AB (Stockholm, Sweden), General Manager at Marklas BV (Woerden, Netherlands) and Regional Director Business Support at Actelion Ltd (Basel, Switzerland, listed at SIX Swiss Exchange).